NANOPARTIKEL MIT TACROLIMUS
European patent · EP3662894 · In force
Register entry
- Publication number
- EP3662894
- Application number
- EP19213120
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Dec 3, 2019
- Published
- Jun 10, 2020
- Granted
- Jul 28, 2021
- Protection ends at the latest
- Dec 2, 2039
- Next annual fee due
- Dec 31, 2026
- IPC classes
- A61K 9/51 (2006.01)A61K 31/436 (2006.01)A61K 9/14 (2006.01)A61K 9/70 (2006.01)A61P 37/06 (2006.01)A61K 31/435 (2006.01)
- Priority
- DE 102018130848 04.12.2018
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jan 1, 2026
Change
Published in Swissreg on 01.01.2026
- Jan 1, 2025
Change
Published in Swissreg on 01.01.2025
- Jan 3, 2024
Address changed
- Owner
- Nucleus Medical GmbH, Am Wildwechsel 7a, 82031 Grünwald, Germany → Nucleus Medical GmbH, Bavariafilmplatz 7, 82031 Grünwald, Germany
Published in Swissreg on 03.01.2024
- Jan 1, 2024
Change
Published in Swissreg on 01.01.2024
- Dec 18, 2023
Transferred
- Owner
- leon-nanodrugs GmbH, Kopernikusstraße 9, 81679 München, Germany → Nucleus Medical GmbH, Am Wildwechsel 7a, 82031 Grünwald, Germany
Published in Swissreg on 18.12.2023
- Jan 1, 2023
Change
Published in Swissreg on 01.01.2023
- Jun 8, 2022
Change
Published in Swissreg on 08.06.2022
- Sep 30, 2021
Agent entered
- Representative
- Felber & Partner AG, Dufourstrasse 116, 8008 Zürich
Published in Swissreg on 30.09.2021
1 earlier entry
- Jul 28, 2021
Granted
Published in Swissreg on 28.07.2021
Parties
Inventor
81545 Munich, DE
81245 Munich, DE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.